论文部分内容阅读
现将我院2001年1月-2004年6月应用拉米夫定治疗失代偿性肝硬化长期疗效报道如下。1材料与方法1.1临床材料15例失代偿性肝硬化均为我院2001年1月-2004年6月反复住院的病例,根据临床表现,血清学指标、电子胃镜、影像学检查、HBVDNA定量等检测方法。诊断活动性肝硬化失代偿期。诊断符合文献[1]标准。肝功能Child-pugh分级:B级9例,C级6例。男12例,女3例,年龄41～65岁,平均年龄54岁。1.2入选与排除标准15例患者病程6～15年,所有患者在疗程中,ALT反复异常,部分病人有不同程度的黄疸,低蛋
Now our hospital January 2001 - June 2004 application of lamivudine treatment of decompensated cirrhosis long-term results are reported below. 1 Materials and Methods 1.1 Clinical Materials 15 cases of decompensated cirrhosis were hospitalized in our hospital from January 2001 to June 2004 repeatedly hospitalized cases, according to clinical manifestations, serological indicators, gastroscopy, imaging studies, HBVDNA quantitative Other detection methods. Diagnosis of active cirrhosis decompensation. Diagnosis consistent with the literature [1] standard. Child-pugh liver function classification: B grade in 9 cases, C grade in 6 cases. There were 12 males and 3 females, aged from 41 to 65 years, with an average age of 54 years. 1.2 The inclusion and exclusion criteria 15 patients with duration of 6 to 15 years, all patients in the course of treatment, ALT repeated abnormalities, some patients have different degrees of jaundice, low eggs